Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver From Morbidly Obese Women
Obesity, 06/08/2012Terra X et al.
The results obtained in morbidly obese (MO) women with nonalcoholic fatty liver disease (NAFLD), brings up the use of retinol binding protein–4 (RBP4) and other adipokines as a panel of noninvasive molecular biomarkers when NAFLD is suspected. Further studies are needed with other obesity groups.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.